ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,685.92
-0.34%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cyclo Therapeutics Inc (CYTH) Share Price

CYTH Cyclo Therapeutics Inc

0.00
0.00 (0.00%)
- - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Cyclo Therapeutics Inc NASDAQ:CYTH NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 0.00 0.00 0.00 0.00 0.00      
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 1.08M -20.06M -0.7009 -1.75 35.2M
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore CYTH News
25/06/202414:25BWCyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024
14/06/202421:01GLOBERafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
30/05/202414:00BWCyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
16/05/202413:05BWCyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
18/03/202413:05BWCyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
14/03/202413:34BWCyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease
13/03/202421:04GLOBERafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
Period
Draw mode
Data Downloads for CYTH

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Cyclo Therapeutics Inc Articles